ArticleKidney diseases (Basel, Switzerland)
Association of Remnant Cholesterol with Rapid Kidney Function Decline in Middle-Aged and Older Adults with Normal Kidney Function.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association between cumulative changes of the C-reactive protein-triglyceride glucose index and the incidence of rapid kidney function decline: a nationwide prospective cohort study.Frontiers in nutrition · 2026Article
- Lipid-Derived Cardiometabolic Indices in Normouricemic and Hyperuricemic Adults: A Retrospective Cross-Sectional Association Study.Healthcare (Basel, Switzerland) · 2025Article
- Association of multiple cholesterol-related indices with diabetic nephropathy: A cross-sectional analysis of the NHANES database.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Emerging evidence suggests a potential association between dyslipidemia and renal dysfunction. Remnant cholesterol, defined as the cholesterol content of triglyceride-rich lipoproteins, has not been thoroughly investigated in relation to rapid renal function decline in individuals with preserved kidney function. Therefore, our study aimed to clarify this association in a nationwide Chinese cohort. Methods: Our study used data from the 2011 and 2015 waves of the China Health and Retirement Longitudinal Study. Remnant cholesterol level was derived using the following equation: total cholesterol minus low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol. The study outcomes were rapid kidney function decline or the progression to chronic kidney disease (CKD). To determine the associations between remnant cholesterol and CKD outcomes, we used multivariable logistic regression, subgroup analyses, restricted cubic spline models, and receiver operating characteristic curve analysis. Results: A total of 4,039 individuals (59 ± 8.7 years, 52.5% female) were enrolled in our study. Over a 4-year follow-up, 195 (4.8%) individuals experienced rapid renal function decline, and 367(9.1%) individuals experienced progression to CKD. Elevated remnant cholesterol levels were strongly linked to an elevated risk of rapid renal function decline (OR = 1.89, 95% CI: 1.59-2.26, Conclusion: Our study demonstrated that elevated remnant cholesterol concentrations were associated with a higher risk of rapid renal function decline among middle-aged and older Chinese adults. These findings suggest that remnant cholesterol may serve as a valuable biomarker for identifying individuals at elevated risk for renal dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.